Sort of. Reuters summarized the results of Vivus’ new weight-loss drug study as follows:
Vivus, whose shares shot up nearly 80 percent on the news, combined phentermine with the epilepsy drug topiramate, available generically [and as] Topamax. […]
Phentermine takes an old-fashioned and logical approach to weight loss — it is a stimulant that speeds up the metabolism. Topiramate, an anti-convulsant, has been shown to interfere with binge eating and studies show it can help patients lose weight and lower their blood pressure. […]
Losing just 10 percent of body weight is enough to lower cholesterol, reduce the risk of diabetes and death. […]
Only—-what are the contraindications for phentermine? Well, per Wikipedia, among those who should not use phentermine are those who have “severe high blood pressure, … heart or blood vessel disease, or severe narrowing of the blood vessels”. Also, among the “medical conditions that may interact” with phentermine and thus may mean avoiding it are those with “high blood pressure, diabetes, or high cholesterol or lipid levels.”
So this is going to be pushed as a “treatment” for high blood pressure, high cholesterol, or diabetes … but it can’t always be used by those with high blood pressure, high cholesterol, or diabetes …? How’s that work again?
Oh right. Many fat people do not have these ills. They can sell it to them!
I also noticed something that is very common:
About 60 percent of U.S. adults are overweight or obese and about 9 million are morbidly obese, with a body mass index above 40.
Notice how they mixed their numbers, going from “60 percent” to “9 million”. Why not give the percentage for those who are morbidly obese? The current US population is estimated to be 304 million. 9 / 304=0.0296052632. Rounding would take it to 3%. Is 3% not scary enough?
Leave a Reply